Company intelligence / Profile preview

iPACS

Taipei, Taiwan

Ownership: Private
Employees: ~100
Development stage: Other

Overview

iPACS is a specialized Imaging Contract Research Organization (CRO) that provides comprehensive medical imaging services for clinical trials. The company offers end-to-end solutions including imaging protocol design, site training, image management, and independent central review. iPACS leverages its proprietary technology platform to ensure high-quality data for regulatory submissions in therapeutic areas such as oncology, cardiology, and neurology. By integrating clinical expertise with advanced imaging technology, iPACS supports pharmaceutical and biotech companies in accelerating their drug development processes.

Therapeutic areas: RheumatologyOncologyCardiovascularNeurology
Industry: Contract Research Organization

Beyond the preview

Go deeper on iPACS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iPACS.

Explore the full profile